|
MKKS expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.50549999823025E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.575060E-04 |
| Normal-vs-Stage2 |
7.765000E-03 |
| Normal-vs-Stage3 |
3.140200E-03 |
| Normal-vs-Stage4 |
2.879800E-02 |
| Stage1-vs-Stage2 |
4.576200E-01 |
| Stage1-vs-Stage3 |
1.566610E-01 |
| Stage1-vs-Stage4 |
3.764200E-01 |
| Stage2-vs-Stage3 |
6.730600E-01 |
| Stage2-vs-Stage4 |
7.503400E-01 |
| Stage3-vs-Stage4 |
9.546200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.14480000004791E-06 |
| Normal-vs-AfricanAmerican |
2.917500E-03 |
| Normal-vs-Asian |
3.816400E-01 |
| Caucasian-vs-AfricanAmerican |
8.879600E-01 |
| Caucasian-vs-Asian |
8.115800E-01 |
| AfricanAmerican-vs-Asian |
8.468400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.58489999697076E-08 |
| Normal-vs-Female |
6.337300E-03 |
| Male-vs-Female |
3.044200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.607300E-04 |
| Normal-vs-Extreme_Weight |
4.215700E-04 |
| Normal-vs-Obese |
1.724120E-03 |
| Normal-vs-Extreme_Obese |
6.065400E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.568000E-01 |
| Normal_Weight-vs-Obese |
5.962400E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.040200E-01 |
| Extreme_Weight-vs-Obese |
9.793400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.528000E-01 |
| Obese-vs-Extreme_Obese |
4.635000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.244230E-01 |
| Normal-vs-Age(41-60Yrs) |
3.647400E-04 |
| Normal-vs-Age(61-80Yrs) |
1.9379900000005E-05 |
| Normal-vs-Age(81-100Yrs) |
3.165000E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.528200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.510400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.273400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.381400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.679540E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.028100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.214000E-04 |
| Normal-VS-Type2 PRCC |
9.75369995881437E-09 |
| Normal-VS-KIRP CIMP |
3.31690230837012E-11 |
| Normal-VS-Unclassified PRCC |
7.283900E-02 |
| Type1 PRCC-VS-Type2 PRCC |
4.169600E-04 |
| Type1 PRCC-VS-KIRP CIMP |
1.559880E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
7.613600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.976300E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.939700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.624530E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.23099999996368E-06 |
| Normal-vs-N1 |
1.221640E-03 |
| Normal-vs-N2 |
1.8824000025397E-08 |
| N0-vs-N1 |
5.352000E-01 |
| N0-vs-N2 |
6.217899999994E-05 |
| N1-vs-N2 |
1.700300E-02 |
|
|
